Amy Leader

TitleProfessor
InstitutionThomas Jefferson University
DepartmentMedical Oncology
Address834 Chestnut Street
Philadelphia PA 19107
Phone215-955-7739
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Ashare RL, Worster B, Nugent SM, Smith DM, Morasco BJ, Leader AE, Case AA, Meghani SH. Cannabis and opioid perceptions, co-use, and substitution among patients across 4 NCI-Designated Cancer Centers. J Natl Cancer Inst Monogr. 2024 Aug 15; 2024(66):267-274. PMID: 39108237.
      Citations:    
    2. Armache M, Assi S, Wu R, Jain A, Lu J, Gordon L, Jacobs LM, Fundakowski CE, Rising KL, Leader AE, Fakhry C, Mady LJ. Readability of Patient Education Materials in Head and Neck Cancer: A Systematic Review. JAMA Otolaryngol Head Neck Surg. 2024 Jun 20. PMID: 38900443.
      Citations:    
    3. Leader AE, McNair CM, Johnson JM. From Base Pairs to City Squares: Comprehensive Precision Oncology for the Future. Cancer Discov. 2024 Apr 04; 14(4):569-572. PMID: 38571420.
      Citations:    
    4. Loeb S, Keith SW, Cheng HH, Leader AE, Gross L, Sanchez Nolasco T, Byrne N, Hartman R, Brown LH, Pieczonka CM, Gomella LG, Kelly WK, Lallas CD, Handley N, Mille PJ, Mark JR, Brown GA, Chopra S, McClellan A, Wise DR, Hollifield L, Giri VN. TARGET: A Randomized, Noninferiority Trial of a Pretest, Patient-Driven Genetic Education Webtool Versus Genetic Counseling for Prostate Cancer Germline Testing. JCO Precis Oncol. 2024 Mar; 8:e2300552. PMID: 38452310.
      Citations:    
    5. Klassen AC, Lee G, Chiang S, Murray R, Guan M, Lo WJ, Hill L, Leader AE, Manganello J, Massey PM. Did the COVID-19 experience change U.S. parents' attitudes towards HPV vaccination? Results from a national survey. Vaccine. 2024 Feb 14. PMID: 38355317.
      Citations:    
    6. Rising KL, Kemp M, Leader AE, Chang AM, Monick AJ, Guth A, Esteves Camacho T, Laynor G, Worster B. A Prioritized Patient-Centered Research Agenda to Reduce Disparities in Telehealth Uptake: Results from a National Consensus Conference. Telemed Rep. 2023; 4(1):387-395. PMID: 38169980.
      Citations:    
    7. Doherty M, Heintz J, Leader A, Wittenburg D, Ben-Shalom Y, Jacoby J, Castro A, West S. Corrigendum: Guaranteed Income and Financial Treatment Trial (GIFT Trial or GIFTT): a 12-month, randomized controlled trial to compare the effectiveness of monthly unconditional cash transfers to treatment as usual in reducing financial toxicity in people with cancer who have low incomes. Front Psychol. 2023; 14:1320743. PMID: 38152561.
      Citations:    
    8. Worster B, Meghani SH, Leader AE, Nugent SM, Jones KF, Yeager KA, Liou K, Ashare RL. Toward reducing racialized pain care disparities: Approaching cannabis research and access through the lens of equity and inclusion. Cancer. 2023 Nov 09. PMID: 37941524.
      Citations:    
    9. Leader AE, Brandt HM, Briant KJ, Curry G, Ellis K, Gonzalez ET, Guerra CE, Harding G, Hull PC, Israel A, Melillo R, Mesia RJ, Schiffelbein JE, Song Y, Surani Z, Tiro JA, Vadaparampil ST, Vanderpool RC, Paskett ED. Community Outreach and Engagement at U.S. Cancer Centers: Notes from the 3rd Cancer Center Community Impact Forum. Cancer Epidemiol Biomarkers Prev. 2023 Oct 04. PMID: 37791915.
      Citations:    
    10. Doherty M, Heintz J, Leader A, Wittenburg D, Ben-Shalom Y, Jacoby J, Castro A, West S. Corrigendum: Guaranteed Income and Financial Treatment (G.I.F.T.): a 12-month, randomized controlled trial to compare the effectiveness of monthly unconditional cash transfers to treatment as usual in reducing financial toxicity in people with cancer who have low incomes. Front Psychol. 2023; 14:1245878. PMID: 37546474.
      Citations:    
    11. Nelson NG, Lombardo JF, Shimada A, Ruggiero ML, Smith AP, Ko K, Leader AE, Mitchell EP, Simone NL. Physician Perceptions on Cancer Screening for LGBTQ+ Patients. Cancers (Basel). 2023 Jun 01; 15(11). PMID: 37296978.
      Citations:    
    12. Doherty M, Heintz J, Leader A, Wittenberg D, Ben-Shalom Y, Jacoby J, Castro A, West S. Guaranteed Income and Financial Treatment (G.I.F.T.): a 12-month, randomized controlled trial to compare the effectiveness of monthly unconditional cash transfers to treatment as usual in reducing financial toxicity in people with cancer who have low incomes. Front Psychol. 2023; 14:1179320. PMID: 37275728.
      Citations:    
    13. Leader AE, Melillo RJ, Greene Q, Blanding-Godbolt J, Shimada A, Eischen CM, Aplin AE. Engaging community members in cancer research: an assessment of an NCI-designated cancer center. Cancer Causes Control. 2023 Jan 04. PMID: 36598655.
      Citations:    
    14. Shenton LM, Perera U, Leader A, Klassen AC. Perceptions of Facilitators and Barriers to Smoking Cessation Among Patients and Providers in a Cancer Center: A Single Institution Qualitative Exploratory Study. Integr Cancer Ther. 2023 Jan-Dec; 22:15347354231198072. PMID: 37694880.
      Citations:    
    15. McIntire RK, Keith SW, Nowlan T, Butt S, Cambareri K, Callaghan J, Halstead T, Chandrasekar T, Kelly WK, Leader AE. Predictors of consenting to participate in a clinical trial among urban Cancer patients. Contemp Clin Trials. 2022 Dec 22; 125:107061. PMID: 36567059.
      Citations:    
    16. Worster B, Waldman L, Garber G, Zhan T, Lopez A, Trachtenberg O, Handley N, Rising KL, Csik V, Leader A. Increasing equitable access to telehealth oncology care in the COVID-19 National Emergency: Creation of a telehealth task force. Cancer Med. 2022 Oct 10. PMID: 36210751.
      Citations:    
    17. Fiorella M, Alnemri A, Sussman S, Koka A, Johnson J, Cognetti D, Curry J, Mady L, Worster B, Leader AE, Luginbuhl A. Impact of Head and Neck Cancer Diagnosis and Treatment on Patient-Partner Intimacy. Otolaryngol Head Neck Surg. 2022 Sep 20; 1945998221126068. PMID: 36125900.
      Citations:    
    18. Kelly BJ, Leader AE, Henrikson NB. Editorial: Promising strategies for vaccine messages: The message and the source. Front Public Health. 2022; 10:971283. PMID: 36117600.
      Citations:    
    19. Leader AE, Miller-Day M, Rey RT, Selvan P, Pezalla AE, Hecht ML. The impact of HPV vaccine narratives on social media: Testing narrative engagement theory with a diverse sample of young adults. Prev Med Rep. 2022 Oct; 29:101920. PMID: 36161120.
      Citations:    
    20. Leader AE, Mercado J, Klein A, Hyatt C, Gross L, Brandt R, Giri VN. Insight into how patients with prostate cancer interpret and communicate genetic test results: implications for families. J Community Genet. 2022 Jul 22. PMID: 35869324.
      Citations:    
    21. Loeb S, Cheng HH, Leader A, Gross L, Nolasco TS, Byrne N, Wise DR, Hollifield L, Brown LH, Slater E, Pieczonka C, Gomella LG, Kelly WK, Trabulsi EJ, Handley N, Lallas CD, Chandrasekar T, Mille P, Mann M, Mark JR, Brown G, Chopra S, Wasserman J, Phillips J, Somers P, Giri VN. Technology-enhanced AcceleRation of Germline Evaluation for Therapy (TARGET): A randomized controlled trial of a pretest patient-driven webtool vs. genetic counseling for prostate cancer germline testing. Contemp Clin Trials. 2022 Jun 13; 106821. PMID: 35710085.
      Citations:    
    22. Mendoza JA, Miller CA, Martin KJ, Resnicow K, Iachan R, Faseru B, McDaniels-Davidson C, Deng Y, Martinez ME, Demark-Wahnefried W, Leader AE, Lazovich D, Jensen JD, Briant KJ, Fuemmeler BF. Examining the Association of Food Insecurity and Being Up-To-Date for Breast and Colorectal Cancer Screenings. Cancer Epidemiol Biomarkers Prev. 2022 Mar 03. PMID: 35247884.
      Citations:    
    23. Zavodnick J, Wickersham A, Petok A, Worster B, Leader A. "1,000 conversations I'd rather have than that one:" A qualitative study of prescriber experiences with opioids and the impact of a prescription drug monitoring program. J Addict Dis. 2022 Feb 08; 1-10. PMID: 35133217.
      Citations:    
    24. Leader AE, McNair C, Yurick C, Huesser M, Schade E, Stimmel EE, Lerman C, Knudsen KE. Assessing the Coverage of U.S. Cancer Center Primary Catchment Areas. Cancer Epidemiol Biomarkers Prev. 2022 Jan 21. PMID: 35064067.
      Citations:    
    25. Lombardo J, Ko K, Shimada A, Nelson N, Wright C, Chen J, Maity A, Ruggiero ML, Richard S, Papanagnou D, Mitchell E, Leader A, Simone NL. Perceptions of and barriers to cancer screening by the sexual and gender minority community: a glimpse into the health care disparity. Cancer Causes Control. 2022 Apr; 33(4):559-582. PMID: 34984592.
      Citations:    
    26. Giri VN, Shimada A, Leader AE. Predictors of Population Awareness of Cancer Genetic Tests: Implications for Enhancing Equity in Engaging in Cancer Prevention and Precision Medicine. JCO Precis Oncol. 2021; 5. PMID: 34778693.
      Citations:    
    27. Loeb S, Massey P, Leader AE, Thakker S, Falge E, Taneja S, Byrne N, Rose M, Joy M, Walter D, Katz MS, Wong RL, Selvan P, Keith SW, Giri VN. Gaps in Public Awareness About BRCA and Genetic Testing in Prostate Cancer: Social Media Landscape Analysis. JMIR Cancer. 2021 Sep 20; 7(3):e27063. PMID: 34542414.
      Citations:    
    28. Leader AE, Aplin AE. From the Community to the Bench and Back Again: The Value of Patient and Community Engagement in Cancer Research. Cancer Discov. 2021 Sep; 11(9):2135-2138. PMID: 34479970.
      Citations:    
    29. Massey PM, Chiang SC, Rose M, Murray RM, Rockett M, Togo E, Klassen AC, Manganello JA, Leader AE. Development of Personas to Communicate Narrative-Based Information About the HPV Vaccine on Twitter. Front Digit Health. 2021; 3:682639. PMID: 34713151.
      Citations:    
    30. Leader AE, Capparella LM, Waldman LB, Cammy RB, Petok AR, Dean R, Shimada A, Yocavitch L, Rising KL, Garber GD, Worster B, Dicker AP. Digital Literacy at an Urban Cancer Center: Implications for Technology Use and Vulnerable Patients. JCO Clin Cancer Inform. 2021 08; 5:872-880. PMID: 34428075.
      Citations:    
    31. Massey PM, Togo E, Chiang SC, Klassen AC, Rose M, Manganello JA, Leader AE. Identifying HPV vaccine narrative communication needs among parents on social media. Prev Med Rep. 2021 Sep; 23:101488. PMID: 34295614.
      Citations:    
    32. Loeb S, Li R, Sanchez Nolasco T, Byrne N, Cheng HH, Becker D, Leader AE, Giri VN. Barriers and facilitators of germline genetic evaluation for prostate cancer. Prostate. 2021 Aug; 81(11):754-764. PMID: 34057231.
      Citations:    
    33. Chodick G, Leader AE, Larson S. Catch-up HPV Vaccination and Subsequent Uptake of Papanicolaou Testing in A State-mandated Health System. Cancer Prev Res (Phila). 2021 Apr; 14(4):415-420. PMID: 33687944.
      Citations:    
    34. Jeurkar C, Leiby B, Banks J, Leader A, Rudolph S, Mateja G, Rashid SA, Carabasi M, Filicko-O'Hara J, O'Hara W, Wagner JL, Gergis U, Flomenberg N, Grosso D. An Examination of Cytomegalovirus, Socioeconomic Status, Race, and Ethnicity on Outcomes after Haploidentical Hematopoietic Transplantation. Transplant Cell Ther. 2021 Apr; 27(4):327.e1-327.e11. PMID: 33836876.
      Citations:    
    35. Selvan P, Kearney M, Cognetti D, Massey P, Leader A. Exploring Knowledge and Attitudes About Human Papillomavirus Vaccination Among School Nurses in an Urban School District. J Sch Health. 2020 Dec 13. PMID: 33314171.
      Citations:    
    36. Leader AE, Burke-Garcia A, Massey PM, Roark JB. Understanding the messages and motivation of vaccine hesitant or refusing social media influencers. Vaccine. 2021 Jan 08; 39(2):350-356. PMID: 33280856.
      Citations:    
    37. Massey PM, Kearney MD, Hauer MK, Selvan P, Koku E, Leader AE. Dimensions of Misinformation About the HPV Vaccine on Instagram: Content and Network Analysis of Social Media Characteristics. J Med Internet Res. 2020 Dec 03; 22(12):e21451. PMID: 33270038.
      Citations:    
    38. Giri VN, Hyatt C, Leader A. Cancer Screening and Genetic Testing Recommendations for Relatives of Men Undergoing Prostate Cancer Germline Testing: Implications for Practice. J Urol. 2020 12; 204(6):1116-1118. PMID: 32926644.
      Citations:    
    39. Laufer T, Lerner B, Petrich A, Quinn AM, Ernst L, Roop A, Knoblauch J, Leasure NC, Jaslow RJ, Hegarty S, Leader A, Barsevick A. Evaluation of a Technology-Based Survivor Care Plan for Breast Cancer Survivors: Pre-Post Pilot Study. JMIR Cancer. 2019 Dec 20; 5(2):e12090. PMID: 31859683.
      Citations:    
    40. Kearney MD, Selvan P, Hauer MK, Leader AE, Massey PM. Characterizing HPV Vaccine Sentiments and Content on Instagram. Health Educ Behav. 2019 Dec; 46(2_suppl):37-48. PMID: 31742459.
      Citations:    
    41. Giri VN, Selvan P, Mohanty S, Lum R, Serrao S, Leader AE. Exploring Asian Indian views about cancer and participation in cancer research: an evaluation of a culturally tailored educational intervention. J Community Genet. 2019 Sep 14. PMID: 31522341.
      Citations:    
    42. Yasin JT, Leader AE, Petok A, Garber G, Stephens B, Worster B. Validity of the screener and opioid assessment for patients with pain-revised (SOAPP-R) in patients with cancer. J Opioid Manag. 2019 Jul/Aug; 15(4):272-274. PMID: 31637679.
      Citations:    
    43. Budenz A, Klassen A, Leader A, Fisher K, Yom-Tov E, Massey P. HPV vaccine, Twitter, and gay, bisexual and other men who have sex with men. Health Promot Int. 2019 Apr 21. PMID: 31006017.
      Citations:    
    44. Song A, Csik VP, Leader A, Maio V. The Oncology Care Model: Oncology's First Foray Away From Volume and Toward Value-Based Care. Am J Med Qual. 2019 Jan 17; 1062860618824016. PMID: 30650993.
      Citations:    
    45. Zeigler-Johnson C, Keith S, McIntire R, Robinson T, Leader A, Glanz K. Racial and Ethnic Trends in Prostate Cancer Incidence and Mortality in Philadelphia, PA: an Observational Study. J Racial Ethn Health Disparities. 2018 Dec 05. PMID: 30520002.
      Citations:    
    46. Mohanty S, Leader AE, Gibeau E, Johnson C. Using Facebook to reach adolescents for human papillomavirus (HPV) vaccination. Vaccine. 2018 09 25; 36(40):5955-5961. PMID: 30172634.
      Citations:    
    47. Kurian CJ, Leader AE, Thong MSY, Keith SW, Zeigler-Johnson CM. Examining relationships between age at diagnosis and health-related quality of life outcomes in prostate cancer survivors. BMC Public Health. 2018 Aug 23; 18(1):1060. PMID: 30139347.
      Citations:    
    48. Giri VN, Obeid E, Hegarty SE, Gross L, Bealin L, Hyatt C, Fang CY, Leader A. Understanding of multigene test results among males undergoing germline testing for inherited prostate cancer: Implications for genetic counseling. Prostate. 2018 Apr 14. PMID: 29655297.
      Citations:    
    49. McIntire RK, Keith SW, Boamah M, Leader AE, Glanz K, Klassen AC, Zeigler-Johnson CM. A Prostate Cancer Composite Score to Identify High Burden Neighborhoods. Prev Med. 2018 Apr 04; 112:47-53. PMID: 29625131.
      Citations:    
    50. Massey PM, Budenz A, Leader A, Fisher K, Klassen AC, Yom-Tov E. What Drives Health Professionals to Tweet About #HPVvaccine? Identifying Strategies for Effective Communication. Prev Chronic Dis. 2018 Feb 22; 15:E26. PMID: 29470166.
      Citations:    
    51. Leader AE, Mohanty S, Selvan P, Lum R, Giri VN. Exploring Asian Indian and Pakistani views about cancer and participation in cancer genetics research: toward the development of a community genetics intervention. J Community Genet. 2017 Jun 28. PMID: 28660599.
      Citations:    
    52. Massey PM, Leader A, Yom-Tov E, Budenz A, Fisher K, Klassen AC. Applying Multiple Data Collection Tools to Quantify Human Papillomavirus Vaccine Communication on Twitter. J Med Internet Res. 2016 Dec 05; 18(12):e318. PMID: 27919863.
      Citations:    
    53. Barsevick AM, Leader A, Bradley PK, Avery T, Dean LT, DiCarlo M, Hegarty SE. Post-treatment problems of African American breast cancer survivors. Support Care Cancer. 2016 Dec; 24(12):4979-4986. PMID: 27543161.
      Citations:    
    54. Myers RE, Leader AE, Censits JH, Trabulsi EJ, Keith SW, Petrich AM, Quinn AM, Den RB, Hurwitz MD, Lallas CD, Hegarty SE, Dicker AP, Zeigler-Johnson CM, Giri VN, Ayaz H, Gomella LG. Decision Support and Shared Decision Making About Active Surveillance Versus Active Treatment Among Men Diagnosed with Low-Risk Prostate Cancer: a Pilot Study. J Cancer Educ. 2016 Jul 15. PMID: 27418065.
      Citations:    
    55. Bass SB, Leader A, Shwarz M, Greener J, Patterson F. Correlates to Human Papillomavirus Vaccination Status and Willingness to Vaccinate in Low-Income Philadelphia High School Students. J Sch Health. 2015 Aug; 85(8):527-35. PMID: 26149308.
      Citations:    
    56. RamĂ­rez M, Jessop AB, Leader A, Crespo CJ. Acceptability of the human papillomavirus vaccine among diverse Hispanic mothers and grandmothers. Hisp Health Care Int. 2014; 12(1):24-33. PMID: 24865437.
      Citations:    
    57. Leader AE, Michael YL. The Association between Neighborhood Social Capital and Cancer Screening. Am J Health Behav. 2013 Sep; 37(5):683-92. PMID: 23985291.
      Citations:    
    58. Brawner BM, Baker JL, Voytek CD, Leader A, Cashman RR, Silverman R, Peter N, Buchner BJ, Barnes CA, Jemmott LS, Frank I. The Development of a Culturally Relevant, Theoretically Driven HPV Prevention Intervention for Urban Adolescent Females and Their Parents/Guardians. Health Promot Pract. 2013 Jul; 14(4):624-36. PMID: 23099659.
      Citations:    
    59. Gutierrez B, Leung A, Jones KT, Smith P, Silverman R, Frank I, Leader AE. Acceptability of the human papillomavirus vaccine among urban adolescent males. Am J Mens Health. 2013 Jan; 7(1):27-36. PMID: 22892147.
      Citations:    
    60. Kim HS, Bigman CA, Leader AE, Lerman C, Cappella JN. Narrative Health Communication and Behavior Change: The Influence of Exemplars in the News on Intention to Quit Smoking. J Commun. 2012 Jun 1; 62(3):473-492. PMID: 22736808.
      Citations:    
    61. Leader AE, Cashman R, Voytek CD, Baker JL, Brawner BM, Frank I. An exploratory study of adolescent female reactions to direct-to-consumer advertising: the case of the Human Papillomavirus (HPV) Vaccine. Health Mark Q. 2011 Oct; 28(4):372-85. PMID: 22054031.
      Citations:    
    62. Leader A, Daskalakis C, Braddock CH, Kunkel EJ, Cocroft JR, Bereknyei S, Riggio JM, Capkin M, Myers RE. Measuring informed decision making about prostate cancer screening in primary care. Med Decis Making. 2012 Mar-Apr; 32(2):327-36. PMID: 21685377.
      Citations:    
    63. Leader AE, Lerman C, Cappella JN. Nicotine vaccines: will smokers take a shot at quitting? Nicotine Tob Res. 2010 Apr; 12(4):390-7. PMID: 20185516.
      Citations:    
    64. Kelly BJ, Leader AE, Mittermaier DJ, Hornik RC, Cappella JN. The HPV vaccine and the media: how has the topic been covered and what are the effects on knowledge about the virus and cervical cancer? Patient Educ Couns. 2009 Nov; 77(2):308-13. PMID: 19395221.
      Citations:    
    65. Leader AE, Weiner JL, Kelly BJ, Hornik RC, Cappella JN. Effects of information framing on human papillomavirus vaccination. J Womens Health (Larchmt). 2009 Feb; 18(2):225-33. PMID: 19183094.
      Citations:    
    66. Meissner HI, Yabroff KR, Dodd KW, Leader AE, Ballard-Barbash R, Berrigan D. Are patterns of health behavior associated with cancer screening? Am J Health Promot. 2009 Jan-Feb; 23(3):168-75. PMID: 19149421.
      Citations:    
    67. Nguyen GT, Leader AE, Hung WL. Awareness of anticancer vaccines among Asian American women with limited english proficiency: an opportunity for improved public health communication. J Cancer Educ. 2009; 24(4):280-3. PMID: 19838885.
      Citations:    
    68. Yabroff KR, Washington KS, Leader A, Neilson E, Mandelblatt J. Is the promise of cancer-screening programs being compromised? Quality of follow-up care after abnormal screening results. Med Care Res Rev. 2003 Sep; 60(3):294-331. PMID: 12971231.
      Citations:    
    Leader's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (119)
    Explore
    _
    Co-Authors (55)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _